| abstract |
The present invention provides an effective amount of Formula I: [Chemical 1] Or a pharmaceutically acceptable salt thereof is administered to a patient in need of treatment for a method of treating a pathological disorder sensitive to steroid hormone nuclear receptor modulation. In addition, the present invention provides novel pharmaceutical compounds of formula I, including pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions comprising a compound of formula I as an active ingredient. |